Johnson & Johnson Announces $2B Investment in North Carolina Biologics Plant 🌟

In a significant move, Johnson & Johnson is set to invest over $2 billion in a cutting-edge biologics manufacturing plant in Wilson, North Carolina. This major initiative is expected to create 420 jobs and supply essential treatments for oncology, immunology, and neuroscience. Construction is slated to begin in early 2025, with full operational capabilities anticipated soon after. This announcement coincides with the confirmation of layoffs at J&J's New Jersey headquarters, highlighting a strategic shift towards enhancing manufacturing capabilities. The Vice President of Innovative Medicine Supply Chain at J&J emphasized the company's commitment to maintaining a resilient supply chain. This investment aligns with North Carolina's growing reputation as a hub for biopharmaceutical manufacturing, supported by a wealth of talent and resources.

October 2026

S

M

T

W

T

F

S

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31